Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms
Antioxidants · 10.12.2023 · 12 (12) · 2094
DOI: 10.3390/antiox12122094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 10.12.2023. Verfasst von Yang Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, The First Hospital of China Medical University, No. 155 Nanjing North Road, Shenyang 110001, China. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China of the Ministry of Science and Technology of the People's Republic of China, The Liaoning Applied Basic Research Program.
Abstract (Originalsprache)
Nuclear factor-erythroid 2-related factor 2 (Nrf2) has been shown to be a negative regulator of osteoclast differentiation, but the precise mechanisms have not yet been established. We examined the precise roles of Nrf2 in regulating antioxidants and reactive oxygen species (ROS) levels, especially the cytoplasmic and mitochondrial ROS during osteoclastogenesis in vitro. In the current study, we found that the absence of Nrf2 promotes osteoclast differentiation in bone-marrow-derived macrophages (BMMs) and RAW 264.7 cells. The receptor activator of NF-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) significantly lowered the levels of Nrf2 and its downstream antioxidant enzymes at mRNA and/or protein levels during osteoclast differentiation in the BMMs of mice and RAW 264.7 mouse leukemic monocytes. Compared to the wild-type cells, Nrf2-deficient cells exhibited heightened sensitivity to both transient RANKL-induced cytoplasmic ROS and prolonged RANKL and M-CSF-induced cytoplasmic and mitochondrial ROS accumulation. Furthermore, exogenous antioxidant agents, including N-acetyl-cysteine (NAC), diphenyleneiodonium chloride (DPI), and mitoquinone mesylate (MitoQ), exhibited substantial capability to suppress the elevation of ROS levels during osteoclast differentiation induced by Nrf2 deficiency, and they consequently inhibited osteoclast differentiation augmented by the lack of Nrf2. The activation of phosphorylated c-FOS resulting from elevated ROS promoted osteoclast differentiation. The inhibition of c-FOS blocked osteoclast differentiation, which was elevated by Nrf2-deficiency. Taken together, these data reveal that Nrf2 effectively decreased the accumulation of intracellular ROS and the phosphorylation of c-FOS during osteoclastic differentiation by regulating antioxidant enzymes and subsequently inhibited RANKL-induced osteoclast differentiation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, The First Hospital of China Medical University, No. 155 Nanjing North Road, Shenyang 110001, China.
- Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Ministry of Education, China Medical University, No. 77 Puhe Road, Shenyang 110122, China.
- Key Laboratory of Liaoning Province on Toxic and Biological Effects of Arsenic, China Medical University, No. 77 Puhe Road, Shenyang 110122, China.
- Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang 110122, China.
- Central Laboratory, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, No. 44 Xiaoheyan Road, Shenyang 110042, China.
- Department of Biology, Indiana University Indianapolis, 723 West Michigan Street, SL 306, Indianapolis, IN 46202, USA.
ORCID-Profile: Jingbo Pi
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China of the Ministry of Science and Technology of the People's Republic of China
- The Liaoning Applied Basic Research Program
- Liaoning Provincial Department of Science and Technology Doctoral Launch
- National Key R&D Program of China of the Ministry of Science and Technology of the People’s Republic of China
- Liaoning Applied Basic Research Program
Zitieren
APA
Yang, Y., Liu, Z., Wu, J., Bao, S., Wang, Y., Li, J., Song, T., Sun, Y., & Pi, J. (2023). Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms. Antioxidants, 12(12), 2094. https://doi.org/10.3390/antiox12122094
Vancouver
Yang Y, Liu Z, Wu J, Bao S, Wang Y, Li J, et al. Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms. Antioxidants. 2023;12(12):2094. doi:10.3390/antiox12122094
BibTeX
@article{Yang2023,
author = {Yang, Yang and Liu, Zhiyuan and Wu, Jinzhi and Bao, Simeng and Wang, Yanshuai and Li, Jiliang and Song, Tao and Sun, Yongxin and Pi, Jingbo},
title = {Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {12},
pages = {2094},
doi = {10.3390/antiox12122094}
}
EUVIMED